Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantibodies | 23 | 2023 | 112 | 7.320 |
Why?
|
| Antigens, Neoplasm | 18 | 2022 | 77 | 6.200 |
Why?
|
| Carcinoma, Hepatocellular | 12 | 2023 | 158 | 4.520 |
Why?
|
| Liver Neoplasms | 11 | 2023 | 211 | 4.120 |
Why?
|
| Autoantigens | 7 | 2016 | 85 | 2.360 |
Why?
|
| Antibodies, Neoplasm | 7 | 2022 | 20 | 2.180 |
Why?
|
| Autoimmunity | 4 | 2015 | 56 | 1.450 |
Why?
|
| Membrane Proteins | 4 | 2015 | 548 | 1.380 |
Why?
|
| Neoplasms | 8 | 2018 | 1341 | 1.360 |
Why?
|
| Lung Neoplasms | 4 | 2016 | 479 | 1.270 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 158 | 1.260 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 330 | 1.240 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 137 | 1.090 |
Why?
|
| Immunologic Tests | 6 | 2017 | 11 | 1.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 12 | 2016 | 456 | 1.030 |
Why?
|
| Liver Cirrhosis | 6 | 2023 | 64 | 0.950 |
Why?
|
| Cell Proliferation | 7 | 2023 | 1420 | 0.930 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2015 | 41 | 0.870 |
Why?
|
| Proteomics | 5 | 2016 | 363 | 0.840 |
Why?
|
| Case-Control Studies | 10 | 2016 | 1266 | 0.840 |
Why?
|
| Prostatic Neoplasms | 4 | 2016 | 1068 | 0.800 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 2598 | 0.770 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 130 | 0.760 |
Why?
|
| Humans | 42 | 2023 | 42163 | 0.740 |
Why?
|
| Prostatic Hyperplasia | 3 | 2016 | 32 | 0.730 |
Why?
|
| Gene Expression | 4 | 2015 | 692 | 0.640 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 933 | 0.600 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2016 | 8 | 0.590 |
Why?
|
| Microarray Analysis | 3 | 2010 | 64 | 0.590 |
Why?
|
| Breast Neoplasms | 5 | 2016 | 1679 | 0.580 |
Why?
|
| Blotting, Western | 7 | 2016 | 884 | 0.570 |
Why?
|
| Gene Fusion | 1 | 2018 | 7 | 0.570 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2015 | 13 | 0.560 |
Why?
|
| Neoplasm Proteins | 3 | 2015 | 228 | 0.530 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 602 | 0.530 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 382 | 0.520 |
Why?
|
| Apoptosis | 4 | 2023 | 1541 | 0.500 |
Why?
|
| Signal Transduction | 6 | 2016 | 2111 | 0.500 |
Why?
|
| Hepatitis, Chronic | 4 | 2023 | 6 | 0.490 |
Why?
|
| Cell Movement | 3 | 2016 | 640 | 0.470 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 82 | 0.470 |
Why?
|
| Tissue Array Analysis | 4 | 2016 | 79 | 0.460 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 137 | 0.460 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 928 | 0.460 |
Why?
|
| BRCA2 Protein | 1 | 2015 | 50 | 0.460 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 58 | 0.450 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 78 | 0.450 |
Why?
|
| Cell Adhesion | 1 | 2015 | 237 | 0.440 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 52 | 0.440 |
Why?
|
| Cyclin B1 | 1 | 2014 | 18 | 0.430 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2016 | 33 | 0.430 |
Why?
|
| Glutathione Transferase | 1 | 2014 | 90 | 0.430 |
Why?
|
| Early Detection of Cancer | 2 | 2016 | 428 | 0.430 |
Why?
|
| alpha-Fetoproteins | 2 | 2014 | 31 | 0.420 |
Why?
|
| Chemokines, CC | 1 | 2014 | 53 | 0.420 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 201 | 0.410 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 200 | 0.410 |
Why?
|
| Energy Metabolism | 1 | 2014 | 181 | 0.410 |
Why?
|
| Proteome | 3 | 2022 | 150 | 0.390 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 187 | 0.390 |
Why?
|
| Recombinant Proteins | 4 | 2016 | 522 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 297 | 0.380 |
Why?
|
| Aged | 10 | 2016 | 7982 | 0.360 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2015 | 233 | 0.340 |
Why?
|
| Female | 16 | 2016 | 24018 | 0.330 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2015 | 39 | 0.330 |
Why?
|
| Middle Aged | 10 | 2016 | 11819 | 0.330 |
Why?
|
| Male | 13 | 2016 | 22779 | 0.330 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 406 | 0.320 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 188 | 0.310 |
Why?
|
| Cerium | 3 | 2013 | 18 | 0.290 |
Why?
|
| Molecular Biology | 1 | 2009 | 47 | 0.290 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 436 | 0.280 |
Why?
|
| ROC Curve | 3 | 2016 | 157 | 0.270 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 80 | 0.260 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 32 | 0.260 |
Why?
|
| Edwardsiella tarda | 2 | 2015 | 2 | 0.240 |
Why?
|
| Fish Diseases | 2 | 2015 | 8 | 0.240 |
Why?
|
| Enterobacteriaceae Infections | 2 | 2015 | 12 | 0.240 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 557 | 0.230 |
Why?
|
| Neoplasm Staging | 2 | 2016 | 366 | 0.230 |
Why?
|
| Genes, myc | 1 | 2005 | 30 | 0.230 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 223 | 0.220 |
Why?
|
| Tumor Stem Cell Assay | 2 | 2014 | 32 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 196 | 0.220 |
Why?
|
| Calcium | 1 | 2007 | 487 | 0.220 |
Why?
|
| Nanoparticles | 3 | 2016 | 449 | 0.220 |
Why?
|
| Early Diagnosis | 2 | 2014 | 69 | 0.210 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 145 | 0.210 |
Why?
|
| Transfection | 2 | 2015 | 526 | 0.210 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2023 | 7 | 0.200 |
Why?
|
| Adult | 7 | 2016 | 13458 | 0.190 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 2803 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 1 | 2023 | 114 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2015 | 62 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 454 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 206 | 0.180 |
Why?
|
| Zea mays | 2 | 2012 | 74 | 0.170 |
Why?
|
| Disease Progression | 2 | 2016 | 661 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2015 | 534 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2016 | 95 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 438 | 0.150 |
Why?
|
| Prognosis | 2 | 2014 | 850 | 0.150 |
Why?
|
| Young Adult | 3 | 2015 | 4936 | 0.150 |
Why?
|
| Metabolome | 2 | 2015 | 50 | 0.140 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 25 | 0.140 |
Why?
|
| DNA, Complementary | 2 | 2009 | 195 | 0.140 |
Why?
|
| Mammography | 2 | 2016 | 211 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2015 | 170 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 21 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 33 | 0.130 |
Why?
|
| Glycolysis | 1 | 2016 | 71 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2016 | 84 | 0.120 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.120 |
Why?
|
| Quercetin | 1 | 2016 | 46 | 0.120 |
Why?
|
| Antibody Formation | 2 | 2006 | 75 | 0.120 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2015 | 18 | 0.120 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.120 |
Why?
|
| RNA Stability | 1 | 2015 | 28 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2015 | 24 | 0.120 |
Why?
|
| Cichlids | 1 | 2015 | 5 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 254 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2013 | 141 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2017 | 137 | 0.120 |
Why?
|
| Seroepidemiologic Studies | 1 | 2015 | 71 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 62 | 0.120 |
Why?
|
| Prostate | 1 | 2016 | 152 | 0.110 |
Why?
|
| Autophagy | 1 | 2016 | 136 | 0.110 |
Why?
|
| Hydrogen Peroxide | 2 | 2013 | 193 | 0.110 |
Why?
|
| Phenotype | 1 | 2018 | 774 | 0.110 |
Why?
|
| Myoelectric Complex, Migrating | 1 | 2014 | 1 | 0.110 |
Why?
|
| Gastrointestinal Motility | 1 | 2014 | 20 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 64 | 0.110 |
Why?
|
| Immunity, Innate | 1 | 2015 | 168 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 111 | 0.110 |
Why?
|
| Bacterial Vaccines | 1 | 2015 | 129 | 0.110 |
Why?
|
| Esophagus | 1 | 2014 | 44 | 0.110 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 26 | 0.110 |
Why?
|
| Zebrafish | 1 | 2015 | 146 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2014 | 169 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 727 | 0.110 |
Why?
|
| Breast | 1 | 2015 | 139 | 0.110 |
Why?
|
| Paclitaxel | 1 | 2014 | 64 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 236 | 0.100 |
Why?
|
| Glucose | 1 | 2015 | 242 | 0.100 |
Why?
|
| Animals | 6 | 2018 | 16695 | 0.100 |
Why?
|
| Immune Sera | 1 | 2013 | 56 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2014 | 411 | 0.100 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 59 | 0.100 |
Why?
|
| Alginates | 1 | 2012 | 19 | 0.090 |
Why?
|
| Protein Binding | 1 | 2015 | 1076 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 683 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 350 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 518 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 599 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1051 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 503 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2012 | 170 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.090 |
Why?
|
| Time Factors | 1 | 2015 | 1848 | 0.090 |
Why?
|
| Soil Pollutants | 1 | 2012 | 104 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2010 | 34 | 0.080 |
Why?
|
| Reference Standards | 1 | 2009 | 55 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 979 | 0.080 |
Why?
|
| Antioxidants | 1 | 2013 | 439 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2485 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1058 | 0.080 |
Why?
|
| Gene Library | 1 | 2009 | 60 | 0.070 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 318 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 227 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 78 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2007 | 154 | 0.060 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2005 | 95 | 0.050 |
Why?
|
| Plant Shoots | 2 | 2013 | 25 | 0.050 |
Why?
|
| Plant Roots | 2 | 2013 | 180 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 5950 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2015 | 7 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2015 | 75 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 362 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 279 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 284 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 117 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 403 | 0.030 |
Why?
|
| Galactosamine | 1 | 2014 | 4 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 82 | 0.030 |
Why?
|
| Digestion | 1 | 2014 | 14 | 0.030 |
Why?
|
| Duodenum | 1 | 2014 | 15 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 339 | 0.030 |
Why?
|
| Metabolomics | 1 | 2015 | 90 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 222 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 686 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 638 | 0.030 |
Why?
|
| Germination | 1 | 2013 | 11 | 0.030 |
Why?
|
| Chlorophyll | 1 | 2013 | 24 | 0.030 |
Why?
|
| Electrolytes | 1 | 2013 | 30 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2013 | 74 | 0.020 |
Why?
|
| Fluorescence | 1 | 2013 | 113 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2012 | 26 | 0.020 |
Why?
|
| X-Ray Absorption Spectroscopy | 1 | 2012 | 7 | 0.020 |
Why?
|
| Hexuronic Acids | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glucuronic Acid | 1 | 2012 | 8 | 0.020 |
Why?
|
| Materials Testing | 1 | 2012 | 99 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 845 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 157 | 0.020 |
Why?
|
| Soil | 1 | 2012 | 170 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 990 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3701 | 0.020 |
Why?
|